or Try an Advanced Search...

    Technical Analysis for GRI - GRI Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.40 -1.18% 0.00
    GRI closed down 1.18 percent on Wednesday, May 15, 2024, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical GRI trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Shooting Star Candlestick Bearish -1.18%
    Earnings Movers Other -1.18%
    Wide Bands Range Expansion -1.18%
    Earnings Movers Other -1.79%
    Wide Bands Range Expansion -1.79%
    Gapped Down Weakness -1.79%
    Older End-of-Day Signals for GRI ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support about 15 hours ago
    Possible NR7 about 16 hours ago
    Shooting Star Candlestick Entry about 16 hours ago
    Fell Below Previous Day's Low about 16 hours ago
    Down 1% about 16 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    GRI Chart by TradingView
    Basic chart:

    Profile

    GRI Bio, Inc., a development stage biotech company, develops Natural Killer T (NKT) cell-based therapies for liver disease and autoimmunity. Its program includes GRI-0621, an inhibitor of type 1 NKT cells that is developed as an oral therapeutic for liver disease. GRI Bio, Inc. was formerly know as Glycoregimmune, Inc. GRI Bio, Inc. was incorporated in 2009 and is based in LA Jolla, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Immunology Immune System Autoimmunity Liver Disease Natural Killer Cell Lymphocytes T Cell Natural Killer T Cell

    Is GRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 14 GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company Showcase
    May 13 GRI Bio reports Q1 results
    May 13 GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
    May 10 GRI Bio files for $75M mixed shelf
    Apr 29 GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
    Apr 25 GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar
    Apr 16 GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patent
    Apr 8 GRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conference
    Apr 1 GRI Bio reports FY results
    Apr 1 GRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Update
    See more GRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 49.28
    52 Week Low 0.375
    Average Volume 144,499
    200-Day Moving Average 5.63
    50-Day Moving Average 0.58
    20-Day Moving Average 0.43
    10-Day Moving Average 0.41
    Average True Range 0.04
    RSI (14) 26.47
    ADX 18.08
    +DI 14.04
    -DI 21.76
    Chandelier Exit (Long, 3 ATRs) 0.47
    Chandelier Exit (Short, 3 ATRs) 0.50
    Upper Bollinger Bands 0.50
    Lower Bollinger Band 0.36
    Percent B (%b) 0.29
    BandWidth 32.42
    MACD Line -0.06
    MACD Signal Line -0.07
    MACD Histogram 0.0124
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.43
    Resistance 3 (R3) 0.43 0.42 0.42
    Resistance 2 (R2) 0.42 0.42 0.42 0.42
    Resistance 1 (R1) 0.41 0.41 0.41 0.41 0.42
    Pivot Point 0.41 0.41 0.40 0.40 0.41
    Support 1 (S1) 0.39 0.40 0.39 0.39 0.38
    Support 2 (S2) 0.39 0.40 0.39 0.38
    Support 3 (S3) 0.38 0.39 0.38
    Support 4 (S4) 0.37